Race Oncology Investor Relations Material

Race Oncology Limited is an Australian-based pharmaceutical company focused on the development and commercialization of oncology therapies. The company is dedicated to researching and advancing treatments for cancer, particularly through its drug discovery and development programs. Race Oncology employs precision medicine approaches and targets specific cancer-related pathways to address unmet needs in cancer care. The company is headquartered in Sydney, Australia, and its shares are listed on the ASX.